ARCHIVES

Gemcitabine Improves DFS In Resected Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984

NCI Advisory Group, Other Cancer Meetings For May, June

April 30, 1976

NCI: The Times Have Been “Confusing,” Acting NCI Director Niederhuber Admits in Memo.

June 9, 2006

NCI Advisory Group, Other Cancer Meetings For September, October

August 27, 1976

NCI CTEP-Approved Trials For the Month of September

September 26, 2014

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

November 30, 2012